IMR Press / CEOG / Volume 16 / Issue 4 / pii/1634203729201-95087090

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Treatment of ectopic pregnancy with prostaglandin e2
Show Less
1 University Department of Obstetrics and Gynecology -Ljubljana (Yugoslavia)
2 University Institute of Clinical Chemistry and Clinical Biochemistry, Hormonal Laboratory -Ljubljana (Yugoslavia)
Clin. Exp. Obstet. Gynecol. 1989, 16(4), 106–109;
Published: 10 December 1989
Abstract

In 10 patients the treatment of ectopic pregnancy consisted of the use of 0.75 to 2.25 mg of prostaglandin E, (Prostin E,, 1 mg/mL, Upjohn). In 8 patients PGE, was injected in the tubal wall under laparoscopic control, in 2 under the control of vaginal ultrasound probe. The effect of the treatment was controlled by serial determinations of serum beta HCG. In 8 which meant successful treatment of ectopic pregnancy. For persistently elevated beta HCG con-centrations in both patients with PGE2 applied under the ultrasound control, laparotomy had to be performed.
Keywords
Ectopic pregnancy
Prostaglandin E2
Share
Back to top